These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6233003

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
    Stefańska B, Dzieduszycka M, Bontemps-Gracz MM, Borowski E, Martelli S, Supino R, Pratesi G, De Cesare M, Zunino F, Kuśnierczyk H, Radzikowski C.
    J Med Chem; 1999 Sep 09; 42(18):3494-501. PubMed ID: 10479282
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD, Von Hoff DD, McDonald B, Talley RW, McCracken JD, Chen T.
    Cancer Treat Rep; 1982 Sep 09; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract] [Full Text] [Related]

  • 48. The human tumor colony forming assay: review and clinical applications.
    Triedman JK, Witman GB, Chee DO, Triedman LJ.
    R I Med J (1976); 1985 Aug 09; 68(8):361-6. PubMed ID: 3863223
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Species differences in troxacitabine pharmacokinetics and pharmacodynamics: implications for clinical development.
    Gourdeau H, Leblond L, Hamelin B, Dong K, Ouellet F, Boudreau C, Custeau D, Richard A, Gilbert MJ, Jolivet J.
    Clin Cancer Res; 2004 Nov 15; 10(22):7692-702. PubMed ID: 15570003
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Therapeutic activity of mitoxantrone and ametantrone against murine tumors.
    Schabel FM, Corbett TH, Griswold DP, Laster WR, Trader MW.
    Cancer Treat Rev; 1983 Dec 15; 10 Suppl B():13-21. PubMed ID: 6362874
    [No Abstract] [Full Text] [Related]

  • 55. Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivatives.
    Bron D, Dodion P, Rozencweig M, Delforge A, Mattelaer MA, Kenis Y, Stryckmans P.
    Invest New Drugs; 1986 Dec 15; 4(1):11-6. PubMed ID: 3700036
    [Abstract] [Full Text] [Related]

  • 56. Trimetrexate: molecular structures and conformational similarities in two crystal forms.
    Hempel A, Camerman N, Camerman A.
    Cancer Biochem Biophys; 1988 Jul 15; 10(1):25-30. PubMed ID: 2975964
    [Abstract] [Full Text] [Related]

  • 57. Elliptinium, a DNA intercalating agent with broad antitumor activity in a human tumor cloning system.
    Arteaga CL, Kisner DL, Goodman A, von Hoff DD.
    Eur J Cancer Clin Oncol; 1987 Nov 15; 23(11):1621-6. PubMed ID: 3428332
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.